Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Heart Conference 2020

About Conference

Heart Conferences 2020  regards each one of the individuals to go to the "9th International Heart Conference" amidst November 25-26, 2020 at Rome, Italy which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops, Speaker sessions.  

Heart Conferences 2020  will join world-class professors, scientists, researchers, students, Perfusionists, cardiologists to discuss methodology for ailment remediation for heart diseases, Electrocardiography, Heart Failure, Pediatric Cardiology and health disorders.Heart Conferences 2020 are planned to give various information that will keep helpful specialists next to each other of the issues impacting the expectations, finding and treatment of cardiovascular diseases. The assembling of this event will be dealt with around the subject “New Visions in Cardiology for a diverse World". 

Conference Series llc Ltd deals with a meetings of 1000+ Global Events thorough of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe and Asia with sponsorship from 1000 more sensible social requests and disseminates 700+ Open get to journals which contains more than 30000 unmistakable personalities, reputed specialists as article board people.

Key Figures of Heart Conferences 2020

This international conference provides the opportunity for clinicians, scientists, doctors and researchers from all over the world to gather and learn the latest advances in the field of cardiology and healthcare and to exchange scientific ideas and experiences in a distinctive environment.

  • 3 days of scientific exchange
  • 200+ abstracts submitted
  • 30+ scientific sessions
  • 80+ international expert faculty members
  • 100+ healthcare professionals

Heart Congress 2020 is the annual meeting conducted with the support of the Organizing Committee Members and members of the Editorial Board of the supporting cardiology related journals and is aimed at helping support healthcare professionals i.e. cardiologists, surgeons, Perfusionists to deliver the best care possible to patients with cardiovascular diseases.

Young Scientist Benefits:

  • Our conferences provide best Platform for your research through oral presentations.
  • Share the ideas with both eminent researchers and mentors.
  • Young Scientist Award reorganization certificate and memento to the winners
  • Young Scientists will get appropriate and timely information by this Forum.
  • Platform for collaboration among young researchers for better development
  • Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Deadline for Registrations:          

  • Till December 30, 2019 – $399   
  • Till January 30, 2020 – $449        
  • Till February 28, 2020 – $499

Why to attend? 

With people from around the world focused on getting some answers concerning Cardiology and Healthcare, this is one of the opportunities to accomplish the greatest accumulation of individuals from different universities, associations, medical centres etc. This Heart Congress in the year 2020 at Rome, Italy will coordinate, disperse information, meet with recurring pattern and potential investigators and get name affirmation at this 3-day event. Broadly acclaimed keynote & plenary speakers, the most recent frameworks, methodologies, and the most current updates in Cardiology & Heart Surgeries field are indications of this conference.

Market Analysis


Heart Conference 2020 is a two-day conference which is to be held on November 25-26, 2020 Rome, Italy. This will be a great platform to gather and share knowledge, presentations, panel discussions, interactive dialogue about the developing world of cardiology. This conference brings together the researchers, scientists, professors, students, cardiologists who dispense an international forum on extending of approved research.

Cardiology is a branch of medicine dealing with disorders of the heart is it human or animal. This subject is associated with medical diagnosis and treatment of congenital heart defectscoronary artery diseaseheart failurevalvular heart disease and electrophysiology.  Doctors who specialize and practice in this field are called cardiologists, a specialty of internal medicine.

Greatest Achievements in the Field of Cardiology:

  • Electrocardiography
  • Cardiac catheterization
  • Coronary angiography
  • Cardiovascular surgery
  • Invasive cardiology
  • The coronary care unit
  • Cardiovascular drugs
  • Preventive cardiology
  • Echocardiography
  • Pacemakers and internal defibrillators

The United States is a huge market for Cardiology Surgical & Interventional Cardiology devices due to factors like high healthcare expenditures, awareness levels and sophisticated healthcare infrastructure. The market is expected to show a huge growth owing to the presence of high unfilled medical needs mainly coming from China and Japan. The increasing widespread presence of cardiovascular diseases is the leading factor driving the market. The World Heart Federation(WHF) unites 200 members bridging 100 countries in the fight against cardiovascular disease, Global Data research predicts the worldwide market for CMD devices will reach $1.6 billion by 2020.

Conference Image

Rapidly growing fractions within interventional cardiology are expected to be led by new technologies, such as CTO crossers, FFR guidewires and OCT catheters. The vascular access market will grow due to a combination of increasing patient population and the shift towards technologically advanced devices that will continue to gain market share at the expense of older, less expensive devices.

Just like other medical device markets, the interventional cardiology market has been witnessing consolidation in the recent years. Through strategic mergers and acquisitions, large competitors are either entering the overall market or expanding their reach by entering new segments.

bundling of devices at a discount has become risen trend because of consolidation. Bundling is driven by unfavorable reimbursement conditions and larger competitors who have a wide variety of devices to offer across the interventional cardiology market and can negotiate more cost-effective contracts with hospitals and labs. As a result, competitive pressure is expected to contribute to declines in prices across most of the segments in the market around the globe.

The Asia Pacific interventional cardiology devices market is habituated to be a bystander to significant gains, at a CAGR of over 9.0% from 2014 to 2020 due to the increasing popularity of cardiovascular disorders in geriatric and pediatric population, growing awareness about the cost efficacy and efficiency provided by these devices and rising health care expenditure levels.

Conference Image


Both the US and European Interventional Cardiology Markets are largest for coronary stent, coronary balloon cathetercoronary embolic protection device and coronary thrombectomy device markets.

In the United States, Interventional Cardiology procedures are broken into four segments: angiography procedures, angioplasty/PCI procedures, coronary atherectomy procedures, and catherization procedures. Of these, the amount of catherization procedures performed annually in the US is the largest, at just under four million.

The European market has these same four segments and an embolic protection device procedure segment. The amount of catherization procedures are also the largest in Europe, at over five million annually.

Many companies enjoy strong positions in the interventional cardiology device market.

US-headquartered Boston Scientific is the largest firm accounting for 23.3% of world consumption over a total annual sale of $2.8 billion. With an estimated 21.8% of the total market share the second position is held by Abbott Laboratories, not far behind are the Dublin-based Medtronic with estimated sales of $1.3 billion – a 10.6% market share. However, the market leader for coronary stents is Abbott Laboratories with an estimated 24.4% share in the market. Lastly, St. Jude dominates the vascular closure devices segment with 44.8% of the global revenue.

Medtronic offers a vast selection of devices across many market segments, allowing it to gain a strong position in the competitive landscape. The company is expected to increase its share over the forecast period as it continues to implement this comprehensive strategy.

Conference Image

Scope and Importance:

The aim of this meeting is to rejuvenate new thoughts for treatment and to analyze the current market trends for the future of cardiovascular medicines, gadgets, and diagnostics, with an emphasize more on latest items that will be benefit in the area of cardiology. Lectures and session talks will give a far-reaching best in the class refresh of the clinical employments of different strategies in the conclusion, visualization, and administration of basic heart diseases. As the world is ending up progressively against general wellbeing difficulties and dangers for heart diseases bursts.

Products manufactured by the industry related to Cardiology research Globally:-

Past Conference Report

Heart Congress 2019

Past Reports  Gallery  

Euro Heart Failure 2018

In the presence of interprofessional researchers and practitioners involved in the development of high-quality education in all aspects of clinical skills, Conference Series 17th European Heart Disease and Heart Failure Congress was held during March 15-17, 2017 in London, UK.

Conference Series Group played host to a diverse panel of key members of the Euro Heart Failure 2017 community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology and Cardiovascular specialties. This event was really aimed for examining where the real cardio-logical specialties are going to the future and purpose of the event was to provide an opportunity for cross-fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Cardiology, Pediatric Cardiology, Heart Diseases, Echocardiography, Interventional Cardiology, Heart and Blood Vessel Surgeries, Cardiac Nursing, Diabetes, Cardiac Surgeries and the Heart and Heart Failure as well, the two days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Euro Heart Failure 2017 Organizing Committee would like to thank the Moderator of the conference, Dr. Qiuping Zhang, King’s College London British Heart Foundation Centre of Research Excellence, UK, and Dr. Annamaria Vianello, Gabriele Monasterio Foundation, Italy who contributed a lot for the smooth functioning of this event.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by Honourable Guests and members of the Keynote forum. The highlights of the meeting were the eponymous lectures, delivered by:

Eckhard U Alt, Technical University of Munich, Germany & Tulane University, USA

Aris Lacis, University Children Hospital, Latvia

Wei Hua, Fuwai Hospital & Cardiovascular Institute, China

William J Rowe, University of Toledo Medical Center, USA

Yehuda Adler, Sheba Medical Center, Israel

Sunny Po, University of Oklahoma Health Sciences Center, USA

Lingfang Zeng, King's College London, UK

Barbara Petracci, Policlinico San Matteo IRCCS, Italy

Mridula Dhakad, Saudi German Hospital, UAE
These talks were of great interest to the general cardiologists and were enormously informative.

17th European Heart Disease and Heart Failure Congress was a great success with the support of international, multi-professional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access. We are happy to announce our 23rd European Heart Disease and Heart Failure Congress, which will be held during February 19-21, 2018 in Paris, France.

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 25-26, 2020

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by